Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Perrigo Company plc
  6. News
  7. Summary
    PRGO   IE00BGH1M568

PERRIGO COMPANY PLC

(PRGO)
  Report
Delayed Nyse  -  04:00 2022-08-17 pm EDT
39.63 USD   -5.28%
05:00pPerrigo Refutes Involvement in Recent Notice of Dismissal of Claims, Impending Trial Over Heartburn Drug Zantac
MT
04:24pPerrigo releases statement on recent market trading activity
PR
11:27aGSK Says No Payment Made After Zantac Plaintiff Drops Lawsuit
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Perrigo Secures FDA's Final Approval for Omeprazole Heartburn Treatment

05/26/2022 | 09:41am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
All news about PERRIGO COMPANY PLC
05:00pPerrigo Refutes Involvement in Recent Notice of Dismissal of Claims, Impending Trial Ov..
MT
04:24pPerrigo releases statement on recent market trading activity
PR
11:27aGSK Says No Payment Made After Zantac Plaintiff Drops Lawsuit
MT
08/16Plaintiff in first Zantac lawsuit set for trial drops case
RE
08/09PERRIGO CO PLC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
08/09Perrigo Company plc Reports Earnings Results for the Second Quarter and Six Months Ende..
CI
08/09Perrigo Cuts Full-Year Profit View on Currency Headwinds After Mixed Second-Quarter Res..
MT
08/09PERRIGO : REPORTS SECOND QUARTER FISCAL YEAR 2022 FINANCIAL RESULTS FROM CONTINUING OPERAT..
PU
08/09TRANSCRIPT : Perrigo Company plc, Q2 2022 Earnings Call, Aug 09, 2022
CI
08/09Perrigo Company Reports Lower Q2 Earnings, Higher Sales; Revises Full Year Guidance
MT
More news
Analyst Recommendations on PERRIGO COMPANY PLC
More recommendations
Financials (USD)
Sales 2022 4 527 M - -
Net income 2022 - - -
Net Debt 2022 3 689 M - -
P/E ratio 2022 -
Yield 2022 2,58%
Capitalization 5 630 M 5 630 M -
EV / Sales 2022 2,06x
EV / Sales 2023 1,88x
Nbr of Employees 9 900
Free-Float 99,6%
Chart PERRIGO COMPANY PLC
Duration : Period :
Perrigo Company plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PERRIGO COMPANY PLC
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 41,84 $
Average target price 50,00 $
Spread / Average Target 19,5%
EPS Revisions
Managers and Directors
Murray S. Kessler President, Chief Executive Officer & Director
Eduardo Guarita Bezerra Chief Financial Officer & Executive Vice President
Orlando D. Ashford Chairman
Thomas M. Farrington Chief Information Officer & Executive VP
Grainne Quinn Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
PERRIGO COMPANY PLC7.56%5 630
JOHNSON & JOHNSON-2.05%440 572
ELI LILLY AND COMPANY12.34%294 849
PFIZER, INC.-15.56%279 832
ROCHE HOLDING AG-16.74%273 886
ABBVIE INC.5.28%252 042